カテゴリー： QYResearch, 世界, 医療/バイオ

ドセタキセル注射液のグローバル市場2023年：10mg/ml、20mg/ml、40mg/ml、その他

◆英語タイトル：Global Docetaxel Injection Market Research Report 2023

QYResearchが発行した調査報告書（QYR23MA8741）◆商品コード：QYR23MA8741
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2023年3月
◆ページ数：113
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

本調査レポートは世界のドセタキセル注射液市場について調査・分析し、世界のドセタキセル注射液市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（10mg/ml、20mg/ml、40mg/ml、その他）、用途別セグメント分析（腺癌、非小細胞癌、肺癌、卵巣癌、膵臓癌、胃癌、頭頸部癌、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Sanofi、Accord Healthcare、Alkem Labs、AuroMedics Pharma、Dr. Reddy’s Laboratories、Fresenius Kabi、Getwell Oncology、GLS Pharma、Hikma、Hospira、Pfizer、Seacross Pharmaceuticals、Teikoku Pharma USA、Teva Pharmaceuticals USA、Xiromed、Aosaikang Pharmaceutical、Beijing Union Pharmaceutical Factory、Cisen Pharmaceutical、Acebright Pharmaceuticals、Hisun Pharmaceutical、Hanhui Pharmaceutical、Hengrui Pharmaceuticals、Meida Kangjiale、Qilu Pharmaceutical、Taiji Pharmaceutical、Wansheng Pharmaceutical、Main Luck Pharmaceuticals、Yangtze River Pharmaceutical、Chia Tal-tianqing Pharmaceuticalなどが含まれています。世界のドセタキセル注射液市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、ドセタキセル注射液市場規模を推定する際に考慮しました。

・ドセタキセル注射液市場の概要
- 製品の定義
- ドセタキセル注射液のタイプ別セグメント
- 世界のドセタキセル注射液市場規模：タイプ別分析（10mg/ml、20mg/ml、40mg/ml、その他）
- ドセタキセル注射液の用途別セグメント
- 世界のドセタキセル注射液市場規模：用途別分析（腺癌、非小細胞癌、肺癌、卵巣癌、膵臓癌、胃癌、頭頸部癌、その他）
- 世界のドセタキセル注射液市場規模予測（2018年-2029年）
- ドセタキセル注射液の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- ドセタキセル注射液市場の競争状況およびトレンド

・ドセタキセル注射液の地域別市場規模
- 北米のドセタキセル注射液市場規模（2018年-2029年）
- アメリカのドセタキセル注射液市場規模（2018年-2029年）
- ヨーロッパのドセタキセル注射液市場規模（2018年-2029年）
- アジア太平洋のドセタキセル注射液市場規模（2018年-2029年）
- 中国のドセタキセル注射液市場規模（2018年-2029年）
- 日本のドセタキセル注射液市場規模（2018年-2029年）
- 韓国のドセタキセル注射液市場規模（2018年-2029年）
- インドのドセタキセル注射液市場規模（2018年-2029年）
- オーストラリアのドセタキセル注射液市場規模（2018年-2029年）
- 中南米のドセタキセル注射液市場規模（2018年-2029年）
- 中東・アフリカのドセタキセル注射液市場規模（2018年-2029年）

・タイプ別セグメント：10mg/ml、20mg/ml、40mg/ml、その他
- 世界のドセタキセル注射液のタイプ別販売量（2018年-2023年）
- 世界のドセタキセル注射液のタイプ別売上（2018年-2023年）
- 世界のドセタキセル注射液のタイプ別価格

・用途別セグメント：腺癌、非小細胞癌、肺癌、卵巣癌、膵臓癌、胃癌、頭頸部癌、その他
- 世界のドセタキセル注射液の用途別販売量（2018年-2023年）
- 世界のドセタキセル注射液の用途別売上（2018年-2023年）
- 世界のドセタキセル注射液の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Sanofi、Accord Healthcare、Alkem Labs、AuroMedics Pharma、Dr. Reddy’s Laboratories、Fresenius Kabi、Getwell Oncology、GLS Pharma、Hikma、Hospira、Pfizer、Seacross Pharmaceuticals、Teikoku Pharma USA、Teva Pharmaceuticals USA、Xiromed、Aosaikang Pharmaceutical、Beijing Union Pharmaceutical Factory、Cisen Pharmaceutical、Acebright Pharmaceuticals、Hisun Pharmaceutical、Hanhui Pharmaceutical、Hengrui Pharmaceuticals、Meida Kangjiale、Qilu Pharmaceutical、Taiji Pharmaceutical、Wansheng Pharmaceutical、Main Luck Pharmaceuticals、Yangtze River Pharmaceutical、Chia Tal-tianqing Pharmaceutical

・産業チェーンと販売チャネルの分析
- ドセタキセル注射液産業チェーン分析
- ドセタキセル注射液の主要原材料
- ドセタキセル注射液の販売チャネル
- ドセタキセル注射液のディストリビューター
- ドセタキセル注射液の主要顧客

・ドセタキセル注射液市場ダイナミクス
- ドセタキセル注射液の業界動向
- ドセタキセル注射液市場の成長ドライバ、課題、阻害要因

・調査成果および結論

・調査方法とデータソース

Highlights
The global Docetaxel Injection market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Docetaxel Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Docetaxel Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Docetaxel Injection include Sanofi, Accord Healthcare, Alkem Labs, AuroMedics Pharma, Dr. Reddy’s Laboratories, Fresenius Kabi, Getwell Oncology, GLS Pharma and Hikma, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Docetaxel Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Docetaxel Injection.
The Docetaxel Injection market size, estimations, and forecasts are provided in terms of sales volume (K L) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Docetaxel Injection market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Docetaxel Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Sanofi
Accord Healthcare
Alkem Labs
AuroMedics Pharma
Dr. Reddy’s Laboratories
Fresenius Kabi
Getwell Oncology
GLS Pharma
Hikma
Hospira
Pfizer
Seacross Pharmaceuticals
Teikoku Pharma USA
Teva Pharmaceuticals USA
Xiromed
Aosaikang Pharmaceutical
Beijing Union Pharmaceutical Factory
Cisen Pharmaceutical
Acebright Pharmaceuticals
Hisun Pharmaceutical
Hanhui Pharmaceutical
Hengrui Pharmaceuticals
Meida Kangjiale
Qilu Pharmaceutical
Taiji Pharmaceutical
Wansheng Pharmaceutical
Main Luck Pharmaceuticals
Yangtze River Pharmaceutical
Chia Tal-tianqing Pharmaceutical
Segment by Type
10mg/ml
20mg/ml
40mg/ml
Others
Segment by Application
Adenocarcinoma
Non-small Cell Tumor
Lung Cancer
Ovarian Cancer
Pancreatic Cancer
Stomach Cancer
Head and Neck Cancer
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Docetaxel Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Docetaxel Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Docetaxel Injection Market Overview
1.1 Product Overview and Scope of Docetaxel Injection
1.2 Docetaxel Injection Segment by Type
1.2.1 Global Docetaxel Injection Market Value Comparison by Type (2023-2029)
1.2.2 10mg/ml
1.2.3 20mg/ml
1.2.4 40mg/ml
1.2.5 Others
1.3 Docetaxel Injection Segment by Application
1.3.1 Global Docetaxel Injection Market Value by Application: (2023-2029)
1.3.2 Adenocarcinoma
1.3.3 Non-small Cell Tumor
1.3.4 Lung Cancer
1.3.5 Ovarian Cancer
1.3.6 Pancreatic Cancer
1.3.7 Stomach Cancer
1.3.8 Head and Neck Cancer
1.3.9 Others
1.4 Global Docetaxel Injection Market Size Estimates and Forecasts
1.4.1 Global Docetaxel Injection Revenue 2018-2029
1.4.2 Global Docetaxel Injection Sales 2018-2029
1.4.3 Global Docetaxel Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Docetaxel Injection Market Competition by Manufacturers
2.1 Global Docetaxel Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Docetaxel Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Docetaxel Injection Average Price by Manufacturers (2018-2023)
2.4 Global Docetaxel Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Docetaxel Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Docetaxel Injection, Product Type & Application
2.7 Docetaxel Injection Market Competitive Situation and Trends
2.7.1 Docetaxel Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Docetaxel Injection Players Market Share by Revenue
2.7.3 Global Docetaxel Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Docetaxel Injection Retrospective Market Scenario by Region
3.1 Global Docetaxel Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Docetaxel Injection Global Docetaxel Injection Sales by Region: 2018-2029
3.2.1 Global Docetaxel Injection Sales by Region: 2018-2023
3.2.2 Global Docetaxel Injection Sales by Region: 2024-2029
3.3 Global Docetaxel Injection Global Docetaxel Injection Revenue by Region: 2018-2029
3.3.1 Global Docetaxel Injection Revenue by Region: 2018-2023
3.3.2 Global Docetaxel Injection Revenue by Region: 2024-2029
3.4 North America Docetaxel Injection Market Facts & Figures by Country
3.4.1 North America Docetaxel Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Docetaxel Injection Sales by Country (2018-2029)
3.4.3 North America Docetaxel Injection Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Docetaxel Injection Market Facts & Figures by Country
3.5.1 Europe Docetaxel Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Docetaxel Injection Sales by Country (2018-2029)
3.5.3 Europe Docetaxel Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Docetaxel Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Docetaxel Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Docetaxel Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Docetaxel Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Docetaxel Injection Market Facts & Figures by Country
3.7.1 Latin America Docetaxel Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Docetaxel Injection Sales by Country (2018-2029)
3.7.3 Latin America Docetaxel Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Docetaxel Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Docetaxel Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Docetaxel Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Docetaxel Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Docetaxel Injection Sales by Type (2018-2029)
4.1.1 Global Docetaxel Injection Sales by Type (2018-2023)
4.1.2 Global Docetaxel Injection Sales by Type (2024-2029)
4.1.3 Global Docetaxel Injection Sales Market Share by Type (2018-2029)
4.2 Global Docetaxel Injection Revenue by Type (2018-2029)
4.2.1 Global Docetaxel Injection Revenue by Type (2018-2023)
4.2.2 Global Docetaxel Injection Revenue by Type (2024-2029)
4.2.3 Global Docetaxel Injection Revenue Market Share by Type (2018-2029)
4.3 Global Docetaxel Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Docetaxel Injection Sales by Application (2018-2029)
5.1.1 Global Docetaxel Injection Sales by Application (2018-2023)
5.1.2 Global Docetaxel Injection Sales by Application (2024-2029)
5.1.3 Global Docetaxel Injection Sales Market Share by Application (2018-2029)
5.2 Global Docetaxel Injection Revenue by Application (2018-2029)
5.2.1 Global Docetaxel Injection Revenue by Application (2018-2023)
5.2.2 Global Docetaxel Injection Revenue by Application (2024-2029)
5.2.3 Global Docetaxel Injection Revenue Market Share by Application (2018-2029)
5.3 Global Docetaxel Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sanofi Docetaxel Injection Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Accord Healthcare
6.2.1 Accord Healthcare Corporation Information
6.2.2 Accord Healthcare Description and Business Overview
6.2.3 Accord Healthcare Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Accord Healthcare Docetaxel Injection Product Portfolio
6.2.5 Accord Healthcare Recent Developments/Updates
6.3 Alkem Labs
6.3.1 Alkem Labs Corporation Information
6.3.2 Alkem Labs Description and Business Overview
6.3.3 Alkem Labs Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Alkem Labs Docetaxel Injection Product Portfolio
6.3.5 Alkem Labs Recent Developments/Updates
6.4 AuroMedics Pharma
6.4.1 AuroMedics Pharma Corporation Information
6.4.2 AuroMedics Pharma Description and Business Overview
6.4.3 AuroMedics Pharma Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 AuroMedics Pharma Docetaxel Injection Product Portfolio
6.4.5 AuroMedics Pharma Recent Developments/Updates
6.5 Dr. Reddy’s Laboratories
6.5.1 Dr. Reddy’s Laboratories Corporation Information
6.5.2 Dr. Reddy’s Laboratories Description and Business Overview
6.5.3 Dr. Reddy’s Laboratories Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Dr. Reddy’s Laboratories Docetaxel Injection Product Portfolio
6.5.5 Dr. Reddy’s Laboratories Recent Developments/Updates
6.6 Fresenius Kabi
6.6.1 Fresenius Kabi Corporation Information
6.6.2 Fresenius Kabi Description and Business Overview
6.6.3 Fresenius Kabi Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Fresenius Kabi Docetaxel Injection Product Portfolio
6.6.5 Fresenius Kabi Recent Developments/Updates
6.7 Getwell Oncology
6.6.1 Getwell Oncology Corporation Information
6.6.2 Getwell Oncology Description and Business Overview
6.6.3 Getwell Oncology Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Getwell Oncology Docetaxel Injection Product Portfolio
6.7.5 Getwell Oncology Recent Developments/Updates
6.8 GLS Pharma
6.8.1 GLS Pharma Corporation Information
6.8.2 GLS Pharma Description and Business Overview
6.8.3 GLS Pharma Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.8.4 GLS Pharma Docetaxel Injection Product Portfolio
6.8.5 GLS Pharma Recent Developments/Updates
6.9 Hikma
6.9.1 Hikma Corporation Information
6.9.2 Hikma Description and Business Overview
6.9.3 Hikma Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Hikma Docetaxel Injection Product Portfolio
6.9.5 Hikma Recent Developments/Updates
6.10 Hospira
6.10.1 Hospira Corporation Information
6.10.2 Hospira Description and Business Overview
6.10.3 Hospira Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Hospira Docetaxel Injection Product Portfolio
6.10.5 Hospira Recent Developments/Updates
6.11 Pfizer
6.11.1 Pfizer Corporation Information
6.11.2 Pfizer Docetaxel Injection Description and Business Overview
6.11.3 Pfizer Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Pfizer Docetaxel Injection Product Portfolio
6.11.5 Pfizer Recent Developments/Updates
6.12 Seacross Pharmaceuticals
6.12.1 Seacross Pharmaceuticals Corporation Information
6.12.2 Seacross Pharmaceuticals Docetaxel Injection Description and Business Overview
6.12.3 Seacross Pharmaceuticals Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Seacross Pharmaceuticals Docetaxel Injection Product Portfolio
6.12.5 Seacross Pharmaceuticals Recent Developments/Updates
6.13 Teikoku Pharma USA
6.13.1 Teikoku Pharma USA Corporation Information
6.13.2 Teikoku Pharma USA Docetaxel Injection Description and Business Overview
6.13.3 Teikoku Pharma USA Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Teikoku Pharma USA Docetaxel Injection Product Portfolio
6.13.5 Teikoku Pharma USA Recent Developments/Updates
6.14 Teva Pharmaceuticals USA
6.14.1 Teva Pharmaceuticals USA Corporation Information
6.14.2 Teva Pharmaceuticals USA Docetaxel Injection Description and Business Overview
6.14.3 Teva Pharmaceuticals USA Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Teva Pharmaceuticals USA Docetaxel Injection Product Portfolio
6.14.5 Teva Pharmaceuticals USA Recent Developments/Updates
6.15 Xiromed
6.15.1 Xiromed Corporation Information
6.15.2 Xiromed Docetaxel Injection Description and Business Overview
6.15.3 Xiromed Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Xiromed Docetaxel Injection Product Portfolio
6.15.5 Xiromed Recent Developments/Updates
6.16 Aosaikang Pharmaceutical
6.16.1 Aosaikang Pharmaceutical Corporation Information
6.16.2 Aosaikang Pharmaceutical Docetaxel Injection Description and Business Overview
6.16.3 Aosaikang Pharmaceutical Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Aosaikang Pharmaceutical Docetaxel Injection Product Portfolio
6.16.5 Aosaikang Pharmaceutical Recent Developments/Updates
6.17 Beijing Union Pharmaceutical Factory
6.17.1 Beijing Union Pharmaceutical Factory Corporation Information
6.17.2 Beijing Union Pharmaceutical Factory Docetaxel Injection Description and Business Overview
6.17.3 Beijing Union Pharmaceutical Factory Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Beijing Union Pharmaceutical Factory Docetaxel Injection Product Portfolio
6.17.5 Beijing Union Pharmaceutical Factory Recent Developments/Updates
6.18 Cisen Pharmaceutical
6.18.1 Cisen Pharmaceutical Corporation Information
6.18.2 Cisen Pharmaceutical Docetaxel Injection Description and Business Overview
6.18.3 Cisen Pharmaceutical Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Cisen Pharmaceutical Docetaxel Injection Product Portfolio
6.18.5 Cisen Pharmaceutical Recent Developments/Updates
6.19 Acebright Pharmaceuticals
6.19.1 Acebright Pharmaceuticals Corporation Information
6.19.2 Acebright Pharmaceuticals Docetaxel Injection Description and Business Overview
6.19.3 Acebright Pharmaceuticals Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Acebright Pharmaceuticals Docetaxel Injection Product Portfolio
6.19.5 Acebright Pharmaceuticals Recent Developments/Updates
6.20 Hisun Pharmaceutical
6.20.1 Hisun Pharmaceutical Corporation Information
6.20.2 Hisun Pharmaceutical Docetaxel Injection Description and Business Overview
6.20.3 Hisun Pharmaceutical Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Hisun Pharmaceutical Docetaxel Injection Product Portfolio
6.20.5 Hisun Pharmaceutical Recent Developments/Updates
6.21 Hanhui Pharmaceutical
6.21.1 Hanhui Pharmaceutical Corporation Information
6.21.2 Hanhui Pharmaceutical Docetaxel Injection Description and Business Overview
6.21.3 Hanhui Pharmaceutical Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.21.4 Hanhui Pharmaceutical Docetaxel Injection Product Portfolio
6.21.5 Hanhui Pharmaceutical Recent Developments/Updates
6.22 Hengrui Pharmaceuticals
6.22.1 Hengrui Pharmaceuticals Corporation Information
6.22.2 Hengrui Pharmaceuticals Docetaxel Injection Description and Business Overview
6.22.3 Hengrui Pharmaceuticals Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.22.4 Hengrui Pharmaceuticals Docetaxel Injection Product Portfolio
6.22.5 Hengrui Pharmaceuticals Recent Developments/Updates
6.23 Meida Kangjiale
6.23.1 Meida Kangjiale Corporation Information
6.23.2 Meida Kangjiale Docetaxel Injection Description and Business Overview
6.23.3 Meida Kangjiale Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.23.4 Meida Kangjiale Docetaxel Injection Product Portfolio
6.23.5 Meida Kangjiale Recent Developments/Updates
6.24 Qilu Pharmaceutical
6.24.1 Qilu Pharmaceutical Corporation Information
6.24.2 Qilu Pharmaceutical Docetaxel Injection Description and Business Overview
6.24.3 Qilu Pharmaceutical Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.24.4 Qilu Pharmaceutical Docetaxel Injection Product Portfolio
6.24.5 Qilu Pharmaceutical Recent Developments/Updates
6.25 Taiji Pharmaceutical
6.25.1 Taiji Pharmaceutical Corporation Information
6.25.2 Taiji Pharmaceutical Docetaxel Injection Description and Business Overview
6.25.3 Taiji Pharmaceutical Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.25.4 Taiji Pharmaceutical Docetaxel Injection Product Portfolio
6.25.5 Taiji Pharmaceutical Recent Developments/Updates
6.26 Wansheng Pharmaceutical
6.26.1 Wansheng Pharmaceutical Corporation Information
6.26.2 Wansheng Pharmaceutical Docetaxel Injection Description and Business Overview
6.26.3 Wansheng Pharmaceutical Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.26.4 Wansheng Pharmaceutical Docetaxel Injection Product Portfolio
6.26.5 Wansheng Pharmaceutical Recent Developments/Updates
6.27 Main Luck Pharmaceuticals
6.27.1 Main Luck Pharmaceuticals Corporation Information
6.27.2 Main Luck Pharmaceuticals Docetaxel Injection Description and Business Overview
6.27.3 Main Luck Pharmaceuticals Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.27.4 Main Luck Pharmaceuticals Docetaxel Injection Product Portfolio
6.27.5 Main Luck Pharmaceuticals Recent Developments/Updates
6.28 Yangtze River Pharmaceutical
6.28.1 Yangtze River Pharmaceutical Corporation Information
6.28.2 Yangtze River Pharmaceutical Docetaxel Injection Description and Business Overview
6.28.3 Yangtze River Pharmaceutical Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.28.4 Yangtze River Pharmaceutical Docetaxel Injection Product Portfolio
6.28.5 Yangtze River Pharmaceutical Recent Developments/Updates
6.29 Chia Tal-tianqing Pharmaceutical
6.29.1 Chia Tal-tianqing Pharmaceutical Corporation Information
6.29.2 Chia Tal-tianqing Pharmaceutical Docetaxel Injection Description and Business Overview
6.29.3 Chia Tal-tianqing Pharmaceutical Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.29.4 Chia Tal-tianqing Pharmaceutical Docetaxel Injection Product Portfolio
6.29.5 Chia Tal-tianqing Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Docetaxel Injection Industry Chain Analysis
7.2 Docetaxel Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Docetaxel Injection Production Mode & Process
7.4 Docetaxel Injection Sales and Marketing
7.4.1 Docetaxel Injection Sales Channels
7.4.2 Docetaxel Injection Distributors
7.5 Docetaxel Injection Customers
8 Docetaxel Injection Market Dynamics
8.1 Docetaxel Injection Industry Trends
8.2 Docetaxel Injection Market Drivers
8.3 Docetaxel Injection Market Challenges
8.4 Docetaxel Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ ドセタキセル注射液のグローバル市場2023年：10mg/ml、20mg/ml、40mg/ml、その他(Global Docetaxel Injection Market Research Report 2023)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • ボルチオキセチン臭化水素酸塩錠のグローバル市場2023年：5mg、10mg、20mg

    • ◆H&Iグローバルリサーチのお客様（例）◆